Cinpathogen areas of scientific expertise:
- Hematology/Hematopathology
- Toxicology
- Oncology
- Immunology
- Molecular Pathology and Epidemiology
- Hematopoietic and lymphoid diseases
- Neoplasia
- Inflammatory/immune mediated mechanisms of disease
- Integrated preclinical/clinical trial paradigms
Research areas:
- Progressive bone marrow failure /neoplasia (AA, MDS, AML, CLL, PB/PT-ALL).
- Development of predictive in vitro tests to evaluate potential for development of AA/MDS.
- Screening tests to identify biomarkers and provide early diagnosis, improve sensitivity and specificity of dx classification
- Identification of therapeutically and mechanistically relevant disease classifications
- Correlation of molecular/diagnostic patterns with clinical outcomes
- Identification of polymorphisms of susceptibility
- Analysis of disease prevalence/incidence
- Immunologically based mechanisms of carcinogenesis and clonal selection
- Epigenomics/altered gene expression/target identification
- Identification of biomarkers of susceptibility and outcome
Our
team is available for consultation on study design and feasibility,
health effects, patterns of diseases and environmental issues in China.
Our
research has been published in leading research journals
including